Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Intervention1: Group A: In the beginning of the treatment Langhana, Deepana, Pachana and Mrudu Virechana will be done for 3-4 days for that 3gm of Trikatu Churna twice a day before meal and Eranda Bhr
Sponsors
IPGT and RA
Eligibility
Inclusion criteria
Inclusion criteria: Patients having signs and symptoms of Tamaka Shwasa described in Ayurvedic texts such as Pinasa, Gurghuraka, Greeva Shirisha Sangruhya, Ativativra Vega Shwasa, Kanthodhvamsa, Asinolabahte Saukhyama. And symptoms mentioned in modern texts such as wheezing, coughing, or shortness of breath. Age group: 18 ââ?¬â?? 60 years Chronicity less than 5 years Uncomplicated cases of Tamaka Shwasa Patients willing to participate in trial
Exclusion criteria
Exclusion criteria: Age below 18 years and above 60 years Pregnant and lactating women Patients having complications like core-pulmonale, pulmonary TB, emphysema, pneumonia, cystic fibrosis, malignancy, severe anaemia, renal failure, congestive cardiac failure. Patients suffering from malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes. Patient undergoing regular treatment for any other severe illness and also patient on prolonged corticosteroid use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will break the pathogenesis of Tamaka Shwasa and thus will be effective in the management of Tamaka ShwasaTimepoint: After the followup period | — |
Secondary
| Measure | Time frame |
|---|---|
| The drug will improve the quality of life and thus will act as disease-modifying agent for Tamaka Shwasa.Timepoint: After the followup period | — |
Countries
India
Contacts
Public ContactDr Mandip Goyal
IPGT and RA Jamnagar
Outcome results
None listed